INVEX THERAPEUTICS LTD
ASX:IXCPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 98.5% of what they think they own, once every option and right converts.
1 cash raise in 24 months; proposed issue pending
Minimal because 4 of its 6 signals are quiet.
INVEX THERAPEUTICS LTD has not lodged any Appendix 2A share-issuance filings since January 2024, so no share-count change figure is available. The company raised A$10.0M in a Placement in October 2026, its only capital raise in the past 24 months. Options and rights on issue could convert into 1M new shares, equal to 1.5% of the current share count, with none in the money and the nearest expiry in December 2026. The company has more than 4 quarters of funding at the recent spend rate. Three proposed securities issues (Appendix 3B) are pending, with the nearest expected issue date in November 2026.
Quick answers · 5
Why was IXC in a trading halt?
Invex Therapeutics requested a trading halt on 22 Oct 2026, giving the reason "Pending release of a material acquisition and capital raising announcement". Trading was expected to resume 26 Oct 2026.
Is IXC raising capital?
Invex Therapeutics has 3 proposed issues of securities pending under Appendix 3B as at 28 Oct 2026; the most recent raise announced is Placement of $10.0M on 26 Oct 2026.
How much placement capacity does IXC have left?
Under 1% of the 15% placement capacity left, about 99% used in 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How much cash does IXC have?
In its quarterly cash report for the quarter ended 30 June 2026, Invex Therapeutics reported $4.0M of cash and estimated 0.0 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do IXC's options expire?
Unexercised options and rights equal 1.5% of Invex Therapeutics's shares on issue; the nearest expiry is Dec 2026.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 2 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 26 June 2024 | 3H · cancellation | IXC : ORDINARY FULLY PAID | 75.2M | Appendix 3H |
| 8 Apr 2024 | 3H · cancellation | IXC : ORDINARY FULLY PAID | 75.2M | Appendix 3H |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
1 cash raise in the last 24 months · 1 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
At $0.10 today, 0 securities are in the money (0.0% of shares on issue). No more priced supply until 10× today’s price, which takes it to 1.1M (1.5% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| IXCAI | Options | Price-triggered | $0.68 | 1 Dec 2026 | 1.1M | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
Director dealings
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.